Experimental chemotherapy with 5-arylpyrimidine antifolates: preliminary studies on toxicity and responsiveness of sarcoma 180 to DDMP (NSC-19494) and DDMP with citrovorum factor (NSC-3590). | Cancer Treat Rep;60(5): 547-53, 1976 May. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Experimental chemotherapy with 5-arylpyrimidine antifolates: preliminary studies on toxicity and responsiveness of sarcoma 180 to DDMP (NSC-19494) and DDMP with citrovorum factor (NSC-3590).

Sirotnak, F M; Dorick, D M; Moccio, D M.

Cancer Treat Rep ; 60(5): 547-53, 1976 May.

Article in En | MEDLINE | ID: mdl-1086715

Subject(s)

Antineoplastic Agents/therapeutic use; Leucovorin/therapeutic use; Pyrimidines/therapeutic use; Sarcoma 180/drug therapy; Animals; Antineoplastic Agents/adverse effects; Drug Therapy, Combination; Female; Mice; Pyrimidines/adverse effects

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidines / Sarcoma 180 / Leucovorin / Antineoplastic Agents Limits: Animals Language: En Journal: Cancer Treat Rep Year: 1976 Document type: Article Country of publication: United States

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidines / Sarcoma 180 / Leucovorin / Antineoplastic Agents Limits: Animals Language: En Journal: Cancer Treat Rep Year: 1976 Document type: Article Country of publication: United States